UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Cost-effectiveness of Gatifloxacin vs Ceftriaxone With a Macrolide for the Treatment of Community-Acquired Pneumonia

Chest, 2001-05, Vol.119 (5), p.1439-1448

2001

Volltextzugriff (PDF)

Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters

Journal of antimicrobial chemotherapy, 2003-05, Vol.51 (suppl-1), p.43-47

2003

Volltextzugriff (PDF)

Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals

American journal of health-system pharmacy, 2003-10, Vol.60 (19), p.1962-1970

2003

Volltextzugriff (PDF)

PIN18 - Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with methicillin-resistant s. Aureus (mrsa) skin and soft tissue infections

Value in health, 2015-05, Vol.18 (3), p.A231-A231

2015

Volltextzugriff (PDF)

Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with methicillin-resistant s. Aureus (mrsa) skin and soft tissue infections

Value in health, 2015-05, Vol.18 (3), p.A231-A231

2015

Volltextzugriff (PDF)

What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?

Clinical infectious diseases, 2001-03, Vol.32 (Supplement-1), p.S39-S46

2001

Volltextzugriff (PDF)

Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patients

PharmacoEconomics, 2000-10, Vol.18 (4), p.369-381

2000

Volltextzugriff (PDF)

Linezolid: an oxazolidinone antimicrobial agent

American journal of health-system pharmacy, 2002-12, Vol.59 (24), p.2413-2425

Paladino, JA

2002

Volltextzugriff (PDF)

Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis

PharmacoEconomics, 1994-06, Vol.5 (6), p.505-512

Paladino, J A

1994

Volltextzugriff (PDF)

Economics of Antibiotic Use Policies

Pharmacotherapy, 2004-12, Vol.24 (12P2), p.232S-238S

Paladino, Joseph A.

2004

Volltextzugriff (PDF)

Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic Parameters

Pharmacotherapy, 2000-04, Vol.20 (4), p.417-428

2000

Volltextzugriff (PDF)

Clinical Efficacy of Intravenous followed by Oral Azithromycin Monotherapy in Hospitalized Patients with Community-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1796-1802

2000

Volltextzugriff (PDF)

Cost-effectiveness of IV-to-oral switch therapy: Azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia

Chest, 2002-10, Vol.122 (4), p.1271-1279

2002

Volltextzugriff (PDF)

Economic justification of antimicrobial management programs: implications of antimicrobial resistance

American journal of health-system pharmacy, 2000-10, Vol.57 (suppl 2), p.S10-S12

Paladino, JA

2000

Volltextzugriff (PDF)

Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.457-463

2003

Volltextzugriff (PDF)

Pharmacoeconomics of antimicrobial therapy

American journal of health-system pharmacy, 1999-11, Vol.56 (suppl 3), p.S25-S28

Paladino, JA

1999

Volltextzugriff (PDF)

Reporting pharmacoeconomic evaluations

PharmacoEconomics, 2005-01, Vol.23 (11), p.1073-1073

2005

Volltextzugriff (PDF)

Is more than one quinolone needed in clinical practice?

The Annals of pharmacotherapy, 2001-09, Vol.35 (9), p.1085

Paladino, J A

2001

Volltextzugriff (PDF)

Cefepime: a fourth-generation parenteral cephalosporin

The Annals of pharmacotherapy, 1996-12, Vol.30 (12), p.1414

1996

Volltextzugriff (PDF)

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

The American journal of medicine, 1991-11, Vol.91 (5), p.462-470

1991

Volltextzugriff (PDF)

Benchmark analysis of strategies hospitals use to control antimicrobial expenditures

American journal of health-system pharmacy, 1996-09, Vol.53 (17), p.2054-2062

1996

Volltextzugriff (PDF)

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections

PharmacoEconomics, 1999-11, Vol.16 (5 Pt 2), p.551-561

1999

Volltextzugriff (PDF)

Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy

The Annals of pharmacotherapy, 1997-10, Vol.31 (10), p.1137

1997

Volltextzugriff (PDF)

Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility

American journal of health-system pharmacy, 1999-11, Vol.56 (21), p.2217-2223

1999

Volltextzugriff (PDF)

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

Diagnostic microbiology and infectious disease, 1993-03, Vol.16 (3), p.255-264

1993

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(41)
Pharmacology & Pharmacy
(33)
Biological And Medical Sciences
(20)
Medical Sciences
(18)
Female
(15)
Pharmacology. Drug Treatments
(15)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(14)
Male
(14)
Aged
(12)
Antibacterial Agents
(12)
Adult
(11)
Anti-Bacterial Agents - Therapeutic Use
(11)
Middle Aged
(11)
Infectious Diseases
(9)
Anti-Bacterial Agents - Economics
(8)
Cost-Benefit Analysis
(8)
Economics
(8)
Antibiotics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of Gatifloxacin vs Ceftriaxone With a Macrolide for the Treatment of Community-Acquired Pneumonia

Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters

Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals

PIN18 - Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with methicillin-resistant s. Aureus (mrsa) skin and soft tissue infections

Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with methicillin-resistant s. Aureus (mrsa) skin and soft tissue infections

What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?

Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patients

Linezolid: an oxazolidinone antimicrobial agent

Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis

Economics of Antibiotic Use Policies

Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic Parameters

Clinical Efficacy of Intravenous followed by Oral Azithromycin Monotherapy in Hospitalized Patients with Community-Acquired Pneumonia

Cost-effectiveness of IV-to-oral switch therapy: Azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia

Economic justification of antimicrobial management programs: implications of antimicrobial resistance

Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa

Pharmacoeconomics of antimicrobial therapy

Reporting pharmacoeconomic evaluations

Is more than one quinolone needed in clinical practice?

Cefepime: a fourth-generation parenteral cephalosporin

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

Benchmark analysis of strategies hospitals use to control antimicrobial expenditures

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections

Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy

Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

Suchergebnisse filtern